CD40/CD40L expression in leukocytes from chronic granulomatous disease patients

被引:9
|
作者
Salmen, Siham
Corte, Daniela
Goncalves, Loredana
Barboza, Luisa
Montes, Henry
Calderon, Ali
Berrueta, Lisbeth [1 ]
机构
[1] Univ Los Andes, CAMIULA, Inst Clin Immunol, Merida, Venezuela
[2] Univ Los Andes, CAMIULA, Fac Sci, Lab Parasite Immunol, Merida, Venezuela
关键词
CD40/CD40L; CGD; primary immunodeficiency; neutrophils; T lymphocytes;
D O I
10.1111/j.1600-0463.2007.apm_613.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic granulomatous disease (CGD) is an inherited disorder caused by defects in the NADPH oxidase complex, which generates superoxide, the precursor of hydrogen peroxide (H2O2) and other reactive oxygen derivatives with microbicidal activity. Because CGD patients are at risk of chronic inflammatory manifestations, including inflammatory bowel disease and autoimmune diseases, and it is not clear whether these pathologies are exclusively secondary to altered superoxide production, or whether distinct immunologic defects are involved, we explored cell proliferation, lymphocyte cell counts, immunoglobulin levels, presence of autoimmune antibodies and expression of costimulatory molecules in leukocytes from CGD patients. We found that CGD patients have a diminished phytohemagglutinin-induced proliferation of blood mononuclear cells. Following stimulation with PMA plus ionomycin, a reduced percentage of CD40L expression in T lymphocytes and a diminished expression of CD40 molecules in neutrophils were observed on leukocytes from these patients. Our results suggest an altered interplay between elements of innate and adaptive immunity in CGD patients, which may be reflected in an increased susceptibility to opportunistic infections.
引用
收藏
页码:939 / 947
页数:9
相关论文
共 50 条
  • [1] Expression of CD40 and CD40L in inflammatory bowel disease.
    Liu, Z
    Colpaert, S
    Van den Broeck, C
    D'Haens, G
    Ceuppens, J
    Geboes, K
    Rutgeerts, P
    GASTROENTEROLOGY, 1998, 114 (04) : A1024 - A1024
  • [2] CD40/CD40L system and vascular disease
    F. Santilli
    S. Basili
    P. Ferroni
    G. Davì
    Internal and Emergency Medicine, 2007, 2 : 256 - 268
  • [3] CD40/CD40L system and vascular disease
    Santilli, F.
    Basili, S.
    Ferroni, P.
    Davi, G.
    INTERNAL AND EMERGENCY MEDICINE, 2007, 2 (04) : 256 - 268
  • [4] The Role Of CD40L And CD40 In The Pathogenesis Of Kawasaki Disease
    Parsaud, Leon
    Arjmand, Parnian
    Duong, Trang T.
    Yeung, Rae S.
    CIRCULATION, 2015, 131
  • [5] Irradiation of CD40 and CD40L in inflammatory liver disease
    Leifeld, L
    Dumoulin, FL
    Ramakers, J
    Wolff, M
    Sauerbruch, T
    Spengler, U
    GASTROENTEROLOGY, 1997, 112 (04) : A1318 - A1318
  • [6] The Role Of CD40L And CD40 In The Pathogenesis Of Kawasaki Disease
    Parsaud, Leon
    Arjmand, Parnian
    Duong, Trang T.
    Yeung, Rae S.
    CIRCULATION, 2015, 131
  • [7] CD40/CD40L and cardiovascular risk in patients on haemodialysis: a role for soluble CD40?
    Esposito, Pasquale
    Dal Canton, Antonio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (07) : 2414 - 2415
  • [8] CD40与CD40L研究
    张庶民
    中国生物制品学杂志, 2003, (01) : 63 - 64
  • [9] Modulation of CD40/CD40L expression by factors involved in atherogenesis
    Frediani, D
    Cobra, AL
    Passaglia, MRT
    Hermann, L
    Souza, HP
    FASEB JOURNAL, 2003, 17 (04): : A522 - A523
  • [10] In situ characterization of CD40l and CD40 expression in glomerulonephritis (GN).
    Yellin, MJ
    DAgati, V
    Szabolcs, M
    Parkinson, G
    Han, A
    Baum, D
    Szema, A
    Chess, L
    FASEB JOURNAL, 1996, 10 (06): : 1769 - 1769